OpS may be considered as all Pap-test performed outside an OrS program. For example, some women have Pap-test at their doctor's office during their physical examination independently of personal letter invitation of OrS. In Italy the complete screening history of women diagnosed with invasive cervical cancer has been performed only in Friuli Venezia Giulia -North eastern Italy -. In these region an OrS was initiated in 1999, targeting women aged 25 -64 years, who are invited to have a Pap-test every 3 years. The screening histories of Cervical Intraepithelial Neoplasia (CIN)3 -squamous cell carcinoma in >65 years-old women may be made with study of OpS, because the OrS offers a free-of-charge Pap-test every 3 years to all women aged 25-64 years. In the present study we have examined the screening histories, treatment, human papillomavirus (HPV) detection of CIN3-invasive squamous cell carcinoma in >65 years-old women, diagnosed in the period 2007-2010 with opportunistic Pap-tests in the Cytopathology Section of Institute of Anatomic Pathology of Rovereto Hospital. 
Materials and methods
In the period 2007-2010 the Cytopathology Section of Institute of Anatomic Pathology of Rovereto Hospital have been examined 28589 opportunistic Pap smears. The standard technique of conventional opportunistic Pap smears involves taking two samples (one from the endocervix with cytobrush and one from ectocervix with Ayre spatule) and smearing the cytological materials on two slides. The cytological diagnosis was performed using the 2001 Bethesda System (14) . An experienced cytopathologist whose diagnostic experience exceeds 20 years have examined all abnormal smears and 10% of the normal smears previously observed a senior cytotechnologist. Colposcopic and cervical biopsies were taken by an experienced colposcopist (in practice for more than 10 years) and review by a senior c o l p o s c o p i s t a s p a r t o f t h e r o u t i n e . H P V g e n o t y p i n g b y P C R w a s p e r f o r m e d i n a l l histological specimens (biopsy, cone, hysterectomy) with diagnosis of low grade and high grade intraepithelial lesions and invasive cervical carcinoma.
Results
111 cases (0,38%) of CIN3-squamous cell carcinoma has been identified in 28589 opportunistic Pap smears. The distribution of women for decades is reported in Table 1 . Between the women >64 years-old with CIN3-squamous carcinoma cytological diagnosis all were > 70 years-old and were not invited to OrS because of age > 64 years. We have reported in Table 2 Table 2 . Age, treatment, histological diagnosis, HPV detection in women over 70 years-old with CIN3-squamous cell carcinoma. NOS= not other specified www.intechopen.com
The Pap smear was performed by gynecologist to the woman's initiative. In the Pap smear of keratinizing squamous cell carcinoma the cells showed significant nuclear and cytoplasmic abnormalities, the later usually showing a marked deviation from normal cells of the same origin. The malignant keratinized cells had a characteristic bright orange or occasionally yellow cytoplasm that was dense and lack the transparent qualities of normal squamous cells. The size of keratinized cancer cells may vary from very large, comparable with normal superficial cells, to small, about the size of small parabasal cells. Their shape varies from round or polyhedral to quite irregular and bizarre (Figure 2 ). The nuclei were usually large for the size of the cells. As is often the case in the presence of cytoplasmic keratinization, nuclear pyknosis and karyorrhexis may occur, conferring on the nucleus a dark appearance. "Tadpole" cells were present. They were elongated, club-shaped cells, with one board and one narrow end. The round or irregular hyperchromatic nucleus was eccentrically located within the larger area of the cytoplasm . The degree of cytoplasmic keratinization was variable. The spindly squamoid cells were an unusual finding in the Pap smear. These cells were narrow, elongated, and needle-shaped. Keratinization was not necessarily seen, the cytoplasm may be either eosinophilic or basophilic. The nuclei were nearly always elongated and hypercromatic ( Figure 3 ). www.intechopen.com
The squamous "pearls" was a very rare finding in Pap smear of squamous cell carcinoma. These were concentrically arranged clusters of being squamous cells. The difference between the benign and malignant "pearls" was in the configuration of the nuclei which, in the cancerous pearl, are enlarged and hypercromatic. In the Pap smears of non-keratinizing squamous cell carcinoma the malignant cells were solitary or arranged in syncytia ( Figure  4 ) and show anisokaryosis. The nuclei were relatively large with unevenly distributed, coarsely granular chromatin and may have irregular nucleoli. The Pap smear of CIN-3 were characterised by cells with nuclear-to-cytoplasmatic ratio significantly increased. The cytoplasm remained well-defined resembling that of very immature metaplastic cells. Nuclei tended to be considerably hyperchromatic, and marked irregularities of nuclear envelope might be present. The cytological characteristics of menopause were found in the Pap smear with malignant cells (Figures 5-6 ) and CIN-3. The cytologic patterns of the advanced atrophic menopause were influenced by dryness of the genital tract and scarsity of recoverable cellular material. The predominant cell was of the size and the degree of maturity corresponding to the parabasal cells. Two main effects of dryness might be observed: one was the uniform enlargement of the cell accompanied by a characteristic uniform gray discoloration of the degenerated nucleus; the second was by nuclear pyknosis and karyorrhexis. In the smear material of the eosinophilic pyknotic type there might be a striking variation in cell size and shape. Some cells might be relatively large, approaching the size of superficial cells, whereas others were the size of small parabasal cells. Sheets of spindly cells with elongated cytoplasm and large, pale nuclei may make their appearance in cervical smears and sometimes might be difficult to interpret. Nuclear pyknosis may be quite striking and often simulates the hyperchromasia of cancer cells; one must search for evidence of karyorrhexis in the form of granules of nuclear material within the cytoplasm. In some instances of extreme dryness, the cells break up during the process of smearing and will appear as standards and filaments of blue-staining nuclear material. The endocervical columnar cells in smear of the cervics were usually scarse or absent. When observed , the endocervical cells were smaller than during the childbearing age, although their columnar configuration was still preserved. The nuclei, although of normal size, may appear somewhat hypercromatic, and the cytoplasm was scanty, opaque, and shows no evidence of secretory activity except for an occasional vacuole. One Pap smear CIN-3 and one Pap smear of keratinizing squamous cell carcinoma cointained cells with koilocytotic changes (Figure 7 ). In the biopsies of CIN-3 maturation ( including surface keratinization ) was absent or confined to the superficial third of the epithelium. Nuclear abnormalities were marked throughout most or all of the thickness of the epithelium. Mitotic figures were numerous and were found at all levels if the epithelium. Abnormal mitoses were frequent. Focal koilocytosis was present in one case. Keratinizing squamous cell carcinoma were histologically characterized by mature squamous cells arranged in irregularly shaped nests or cords that varied considerably in size. The most striking feature was the present of keratine pearl within the nests of neoplastic squamous epithelium (Figures 8 and 9 ).
www.intechopen.com Individual squamous cells were large ,with abundant eosinophilic cytoplasm, and many showed individual cell keratinization. The cells were closely apposed and often had prominent intercellular bridges. The nuclei may be enlarged or pyknotic. Mitotic activity was relatively low compared with the other tumor types.
The non-keratinizing tumors were composed of generally recognized polygonal squamous cells that might have individual cell keratinization and intercellular bridge but keratin pearls were absent (Figure 10 ). Cellular and nuclear pleomorphism was more obvious than in the well differentiated tumours, and mitotic figures were usually numerous. 
Discussion
In 1990 cervical cancer comprised 10% of cancers in women for a total of approximately 470,000 cancer cases world-wide (15), representing the third most common cancer in females and the most common cancer in Sub-Saharan Africa., Central America and South Central Asia. Approximately 230,000 women die annually from cervical cancer and over 190,000 of these are from developing countries. Zimbawe and India stand out not only for their high incidence, but also for an unfavourable incidence to mortality ratio. Some relatively highincidence countries can also be found in Eastern and Central Europe (16).The incidence and mortality of invasive squamous cell cervical carcinoma have decreased dramatically in the United States over the last three decades. The incidence in the United States was 34/100,000 in 1947, 15/100,000 in1970, and 12/100,000 in 1986 (17). Although the incidence was decreased in the United States before the implementation of mass cervical cancer screening programs, screening has had an additional major impact on both the incidence and mortality (65,111). The significance of cytologic screening in reducing the incidence of cervical cancer is further underscored by comparing the 4.5/100,000 incidence per year in a screened population to the 29/100,000 incidence in an unscreened population(18). Both cohorts exhibited similar epidemiologic characteristics. In the United States, approximately half of the women who develop cervical cancer have not had a cervical smear in the preceding 3 years(19). According to the most recent global estimates, invasive squamous cell carcinoma is the second most common cancer in women world-wide, with the exception of skin cancer. There are approximately 493,000 new cases of invasive cervical cancer worldwide and 274,000 women die of the disease annually (20). The highest rates are reported in Latin America, where cervical cancer accounts for half of all female cancers. The annual incidence of invasive cervical cancer in women between 30 and 50 years of age in high-risk areas is 1/1,000. In developing countries throughout the world, cervical cancer is a major public health problem and is one of the leading causes of death (21). Recent increases in incidence and mortality rates have been observed in some Western countries including Canada, Great Britain, Sweden, and Norway (22, 23, 24, 25) . In the United States, there were 12,800 new cases and 4,600 cervical cancer deaths in 2000 (26). The incidence among blacks and Hispanics is two times higher than among whites in the United States. Moreover, in a recent study, after adjusting for a number of demographic factors, age, Federation of Gynecology and Obstetrics (FIGO) stage, other tumor characteristics, and treatment, black women had a higher mortality rate than white women, indicating that race is an independent predictor of cervical cancer survival (27). Socioeconomic, religious, sexual, obstetric, dietary factors, immunosuppression, smoking, and oral contraceptive intake have been studied in relation to cervical cancer. Studies suggest that dietary carotenoids and vitamin C have a protective effect against cervical cancer (28,29). The risk of cervical cancer is increased by the number of sexual partners, the age at which sexual intercourse is initiated, and the sexual promiscuity of the male partner. Husbands of women with cervical cancer have more sexual partners than husbands of controls (30). In a recent study, smokers had a two-fold excess risk of cancer, with the risk linked to smoking intensity and duration (31). The effect was most striking among women who had smoked continuously up to the time of cancer diagnosis and women who began smoking late in life, suggesting that smoking played a promotional role in cervical cancer rather than an initiating role. Longduration use of hormonal contraceptives is associated with an increased risk of cervical cancer, but the public health implications depend largely on the extent to which the association remains long after the use of the contraceptives has ceased (31). Invasive squamous cell carcinoma is uncommon before the age of 30 years. Half of the patients, however, are less than 50 years old (32). In the United States, 22 percent of all women with cervical cancer are under the age of 35 years (33), but most are between 45 and 55 years of age al the time of diagnosis. Cervical cancer, however, can occur at almost any age between 17 and 90 years. The majority of the patients present with intermittent painless vagina, bleeding, often first noted after sexual intercourse or douching. With advancing disease, bleeding may become continuous, and be accompanied by a malodorous discharge and pain. Pain is frequently referred in the flank or leg as a result of tumor invasion of the pelvic wall or sciatic nerve. A cervical biopsy is mandatory for diagnosis. Although sampling problems and incorrect interpretation are partly responsible for false negative smears, necrosis and inflammation on the surface of the tumor may result in only an "atypical smear" that lacks obvious tumor cells. Consequently, the cervix that is abnormal by inspection or palpation is biopsied, even if the cytology smear is normal. In addition to biopsy of the ectocervix, an endocervical curettage Is performed as an integral part of the evaluation because invasive carcinoma, particularly adenocarcinoma, frequently involves the endocervical canal and may not be visible on the ectocervix. Cervical cancer is the most common gynecologic cancer to occur during pregnancy: about 3 lo 10 percent of cervical www.intechopen.com cancers occur in pregnant women. In these women, 83 percent present with stage I disease (34). Invasive cervical cancer can be divided in two major histological types: squamous cell carcinoma and adenocarcinoma. In terms of percentages, 80-85% of cases are squamous cell carcinoma, 10% are adenocarcinoma, and 3% are adenosquamous carcinoma and other rare tumours (35). HPV infection is the most common sexually transmitted disease, with more than 80% of the population infected at some time in their life. The main risk factor is undoubtedly genital infection with HPV. HPV infections are found in almost all preinvasive lesions, so-called CIN and invasive squamous cell cancers (36). Based on the stillrising figures of HPV infections, one could consider it to be one of the most prevalent sexually transmitted pathogen diseases worldwide (1). From an epidemiological point of view, an HPV infection meets the criteria as a causal agent for cervical cancer (37, 38) . Current epidemiological and fundamental data have confirmed infection with HPV to be the basic cause of the disease (37,38). Having sexual contact is the main source of HPV infection. It is estimated that for every three people who have sex with a HPV-positive person, two will develop an infection within the next few months (1-19). In the majority of cases (75%), the infection will be asymptomatic. The peak prevalence of genital HPV infections is soon after the onset of sexual activity in women. HPV deoxyribonucleic acid (DNA) persists for about 6-12 months in the genital tract and spontaneously disappears in the majority of patients until an infection with a new type occurs. A persistent infection is the most important risk factor for initiating malignant transformation in the cervical epithelium. The time from initial infection to pre-invasive and, ultimately, invasive disease appears to be at least 10-15 years (1). Based on their association with cervical cancer, genotypes of HPV are divided into low-risk and high-risk groups, according to their presence in malignant lesions of the cervix. Functionally high risk HPV types infection contributes to carcinogenesis and tumour progression predominantly through the action of two viral oncogenes, E6 and E7. The coordinated expression of E6 and E7 has been town to transform rodent cells and immortalize primary human keratinocytes (39,49). The E6 and E7 proteins of high-risk HPVs have been demonstrated to be able to associate with the products of p53 and retinoblastoma susceptibility (Rb) genes, respectively, and inactivate the functions of these tumour suppressor proteins (40,41). The E6 protein exerts rapid degradation of p53, in corporation with E6-associated protein (E6-AP), via ubiquitinmediated proteolysis pathway (42, 43). The E7 protein mediates the release of the E2F transcription factor from pRb-E2F complex (44). Mutational analysis of HPV 16 E6 protein revealed that a certain level of the activity to degrade p53 is required for E6 to manifest its transforming function (45). The p53 mutations are the most frequent genetic abnormalities found in a wide variety of human malignant tumours (46). Once DNA damage occurs, p53 protein is induced and arrests cells in the G1 phase to enhance DNA repair (47), or triggers apoptosis following DNA damage (48). These functions of p53 protein are important to maintain the genomic integrity. Mutant p53 proteins are devoid of these functions, because they lose the ability of DNA contact or destabilize the structure of the core domain (49). In this way, once p53 is mutated, DNA damage is fixed and subsequent genetic rearrangement progress which may be putative mechanisms to initiate cancer. Thus far, exceptionally low prevalence (0-6%) of the p53 mutations had been documented in cervical carcinomas (50, 51, 52, 53, 54) . The p53 protein in cervical carcinoma is thought to be inactivated presumably due to complex formation with HPV E6 oncoprotein. Although Crook et al initially postulated that p53 mutations were confined to the HPVnegative cervical carcinomas (55,56), several recent studies implicated that p53 mutation was a very rare event and the occurrence was not strictly correlated with HPV status in primary cervical carcinomas (50, 51, 52, 53, 54) . It has been also shown that p53 mutants identified in the HPV-positive anogenital cancers exhibit increased resistance to HPV E6-directed degradation, suggesting that mutation of p53 may play a role in the progression of the HPV-positive cervical cancer (56). The p53 mutation has been found only in 0-6% of cervical carcinomas. In light of recent studies demonstrating that mutation of p53 gene was found in over 20% of the patients with vulvar carcinoma (57, 58), a disease of elderly women and a known HPV-related malignancy, Nakagawa et al (59) There was no significant difference in the incidence of lymph node metastasis, histology, and the distribution of clinical stage between the two groups. In elderly Japanese women with stage Ib-IIb, the association of HPV of types other than HPV 16 is suggested to influence the progression of cervical cancer. The most common member of the high-risk group is HPV 16, which accounts for more than 60% of all cervical cancers. The high-risk types account for more than 95% of all cases of cervical cancer. One of the main differences between high-and low-risk types is the possibility of integration in the genome. Approximately 1percent of the high-risk HPV types and only 0.1% of the low-risk HPV www.intechopen.com types will lead to the development of cervical cancer (61). In our case HPV 16 and HPV 58 were detected in two cases of CIN3 and HPV 58 in one case of squamous cell carcinoma. In one case of CIN3 and in 4 cases of squamous cell carcinoma the HPV type has been not detected. Two hypotheses may be made. There is a subset of squamous cell carcinomas that is unrelated to HPV. Other hypothesis takes into account that HPV 16 is only integrated in 72 percent of all invasive cervical cancers(62). The finding of the absence of HPV 16 DNA integration in some carcinomas implies that integration is not always required for malignant progression, but does not exclude the importance of HPV integration in the initiation of cervical cancer. Hypothetically, after the development of a carcinoma, the abnormal clone could lose the viral DNA. HPV 18, on the other hand, shows 100 percent integration. The epidermal growth factor receptor (EGFR) represents a cell membrane receptor characterized by an extracellular ligand-binding domain and an intracellular domain with tyrosine activity involved in signal transduction. EGFR receptor ligands such as epidermal growth factor (EGF) and tumor growth factor > binding to EGFR lead to a cascade of cellular events that are responsible for DNA synthesis, cell proliferation, mutation, survival maturation, and apoptosis (63). Aberrant EGFR expression results in abnormal growth, inhibition of apoptosis, angiogenesis,and the promotion of invasion/metastasis (64). EGFR overexpression has been observed in several malignancies (65). Cyclooxygenase (Cox) is the enzyme involved in the conversion of arachidonic acid to prostaglandins in the critical steps of tumor onset and progression. Two Cox isoforms have been characterized. Cox-1 is expressed constitutively in almost all tissues and serves homeostatic functions. Cox-2, which is highly inducible by growth factors, prostaglandins, and tumor promoters, plays a key role in inflammatory response (66). Cox-2 overexpression has been reported in many neoplasms; its overexpression is associated with carcinogenesis and is linked to proliferation, neoangiogenesis, high microvessel density, and inhibition of apoptosis (67). Some authors have also clarified that the aggressiveness of Cox-2 expression in different malignant neoplasms is due to the ability of this substance to modulate adhesion molecule and protease expression (68,69). To find information on invasive squamous cervical carcinoma in the elderly, Giordano et al ( 70) have analyzed 110 invasive squamous cervical carcinomas obtained from 2 groups of patients for HPV status by polymerase chain reaction study, for immunohistochemical EGFR, Cox-2 expression, and clinicopathologic features. In this study 64 women 60 years or younger were designated as the younger group and 46 who were 61 years or older were designated as the older group. The HPV status and the expression of Cox-2 and EGFR in the younger and older women were compared and correlated with the grading, staging neoplasm, and lymph nodal status. Overall survival curves were drawn using Kaplan-Meier estimates and were compared using log-rank tests in the whole series of 110 patients. The number of neoplasms with higher staging was significantly greater than those in the younger women. The mortality was higher in the older group than in the younger patients. In the elderly, the presence of HPV DNA in 65% of cases, and in the absence of sexual activity, could be due to reactivation of latent HPV infection. In accordance with data provided by the literature, this finding demonstrated that HPV DNA can be detected in elderly women and can be associated with cervical carcinoma (59,71,72). Thus, it is possible that, in elderly women, HPV presence, in the absence of sexual activity, could be due to reactivation of latent HPV infection because of impairment of host immunologic response (73). The overexpression of Cox-2 in a number of cases was significantly higher in the older group than in the younger group, but this immunoreactivity is not related to the staging, grading, EGFR expression, or to the presence of HPV. The simultaneous expression of Cox-2 and EGFR had a poor prognostic significance, showing lower survival rates than cases without this immunoreactivity. On multivariate analysis, Cox-2 and EGFR immunopositivity did not reveal any correlation between these markers and prognosis probably because the number of cases considered was not particularly high. Inadequate immunologic control of HPV infection resulting in viral persistence is likely an important determinant of risk of progression to cervical neoplastic disease. Previous studies have provided evidence supporting this view. Higher prevalence of HPV infection is observed in HIV-infected individuals (74, 75) . Studies have also reported associations between deregulation of cytokine production and impairment of CD4+ T cell-mediated immunity and cervical precancers (76, 77, 78, 79) . Finally, the consistent association observed between HLA alleles and cervical neoplasia argue for a role of the host immune response to HPV in cervical cancer pathogenesis (80). Immunologic competence has been reported to decrease with aging (81-93). Garcia Piňeres et al (72) examined the association between lymphoproliferative responses to antigens/mitogens and persistent HPV infection in women older than 45 years. Women included in this study were participants in a 10,000-woman population-based cohort study of cervical neoplasia in Costa Rica. Women older than 45 years and HPV DNA positive at a screening visit were selected as cases (n = 283). Garcia Piňeres et al selected a comparably sized control group of HPV DNA-negative women, matched to cases on age and time since enrollment (n = 261). At an additional clinical visit, women were cytologically and virologically rescreened, and cervical and blood specimens were collected. Proliferative responses to phytohemagglutinin (PHA), influenza virus (Flu), and HPV16 virus-like particle (VLP) were lower among women with persistent HPV infection [median counts per minute (cpm): 72,849 for PHA, 1,241 for Flu, and 727 for VLP] than for the control group (median cpm: 107,049 for PHA, 2,111 for Flu, and 2,068 for VLP). The decreases were most profound in women with long-term persistence and were only observed for the oldest age group (≥65 years). The results of this study indicate that an impairment in host immunologic responses is associated to persistent HPV infection. The fact that effects were evident for all studied stimuli is suggestive of a generalized effect. Since 1993, at least 7 studies have described the screening histories of women with invasive cervical cancer (95, 96, 97, 98) . The number of cases in these studies was between 469 and 481All studies concluded that the lack of a cervical smear history is the major reason why the disease still occurs. The percentage of women with invasive cervical cancer that had no screening history varied between 28% in Connecticut, USA (99) and 54% for Maori women in New Zealand (100). This percentage strongly depends on the population coverage of screening. With a 100% coverage, the percentage will only include young women diagnosed before the starting age of the programme. In 2007 the almost 30%of the Italian population not included in organised programmes is partly the result of an implementation process still in progress in some Regions in Southern Italy, but mainly of a very limited or completely absent implementation in a few Regions in Northern Italy. In 2008 the extension of organised cervical cancer screening programmes in Italy had had a target population 13.8095.025 women, corresponding to 78,44% of Italian women aged 25-64 years vs 69% in 2006. During 2008, 39.69% of invites women were screened, vs 39.83% in the previous year. The results of single regions are not homogeneous( The data of Liguria region have not been reported.
Legend:
Nominal extension: percentage of the resident population aged 24-64 that is included in the target population of active organised programmes. PPV = Positive predictive value. DR = Detection rate. ASCUS = Atypical squamous cells of undetermined significance. CIN = Cervical Intraepithelial Neoplasia. Zucchetto et al (105) shows that the lack of screening among older women and of compliance with organized programs among women in the target population are the main limitation in cervical cancer secondary prevention. The results of Zucchetto et al (105) are in agreement with research conducted in northen Europe. Bos et al (106) have analized the screening history of 3.175 women with invasive cervical cancer diagnosed in the years 1994-1997 in the Netherland. 57% of 3175 women with invasive cervical cancer had no previous smears. Given the high proportion of women with invasive cervical cancer older than 64 years at diagnosis, the possibility of inviting them to have at least one Pap smear in life after 64 years should be taken in consideration. In according to American Cancer Society Guidelines for the early detection of cancer and the guidelines of other national regional screening programme, women 70 years of age or older who have had 3 or more normal Paptest in a know and no abnormal Pap-test results in the last 10 years may choose to stop having Pap-test. But according to National Cervical Screening program the current policy of screening women of New Zealand is to continue organized regular screening until aged 69 years with pap test every three years if the women have ever been sexually active remain in place. The present study should be support the screening policy to perform Pap test every 3 years until aged 75 years, independently to sexual activity. In older post-menopausal women the transformation zone may be difficult to see. The cervix is often much smaller and the amount of cervical cells found in the smears may be not optimal. We believe that two samples (one from the endocervix with cytobrush and one from ectocervix with Ayre spatule) and smearing the cytological materials on two slides is the procedure of choice in order to obtain adequate material.
